Sarepta Therapeutics (SRPT) Cash from Operations (2010 - 2026)
Sarepta Therapeutics (SRPT) posted quarterly Cash from Operations of 202683000.0 for Q1 2026, up 65.26% year-over-year from 122644539.8 in Q1 2025, and down 254.48% quarter-over-quarter from 131206000.0 in Q4 2025.
Sarepta Therapeutics (SRPT) Cash from Operations (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' Cash from Operations history runs 17 years deep, the most recent figure standing at 202683000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 65.26% year-over-year to 202683000.0; the TTM figure through Mar 2026 stood at 175275000.0 (up 132.03% YoY), while the FY2025 annual figure was 205479000.0, changed 0.15% from the prior year.
- Cash from Operations for Q1 2026 stood at 202683000.0, down from 131206000.0 in the prior quarter.
- The five-year high for Cash from Operations was 261337000.0 in Q2 2025, with the low at 583437000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 70699000.0 (2024), against an average of 84722823.53.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 215.05% in 2022, then surged 1649.01% in 2025.
- Sarepta Therapeutics' Cash from Operations stood at 92392000.0 in 2022, then jumped by 40.84% to 54657000.0 in 2023, then soared by 268.41% to 92046000.0 in 2024, then surged by 42.54% to 131206000.0 in 2025, then plunged by 254.48% to 202683000.0 in 2026.
- Business Quant data shows SRPT's Cash from Operations at 202683000.0 in Q1 2026, 131206000.0 in Q4 2025, and 14585000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Sarepta Therapeutics | 1.91 Bn | 1.12 Bn | 251.87 Mn | 197.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 197.07 Mn |
| Jun 30, 2026 | 197.07 Mn |
| Mar 31, 2026 | -202.68 Mn |
| Mar 31, 2026 | -202.68 Mn |
| Dec 31, 2025 | 131.21 Mn |
| Dec 31, 2025 | 131.21 Mn |
| Sep 30, 2025 | -14.59 Mn |
| Sep 30, 2025 | -14.59 Mn |
| Jun 30, 2025 | 261.34 Mn |
| Jun 30, 2025 | 261.34 Mn |
| Mar 31, 2025 | -583.44 Mn |
| Mar 31, 2025 | -583.44 Mn |
| Dec 31, 2024 | 92.05 Mn |
| Dec 31, 2024 | 92.05 Mn |
| Sep 30, 2024 | -70.70 Mn |
| Sep 30, 2024 | -70.70 Mn |
| Jun 30, 2024 | 14.94 Mn |
| Jun 30, 2024 | 14.94 Mn |
| Mar 31, 2024 | -242.08 Mn |
| Mar 31, 2024 | -242.08 Mn |